Latest Updates

Overview of Substance Use Disorders

    • Discussion of the evolution of DSM substance use disorder diagnoses over time
    • Overview of the biological, environmental, and personal factors implicated in the development of substance use disorders
    • Critical reviews of the current diagnostic criteria, epidemiology, and clinical presentation of the major substances of misuse

Breast Cancer

    • There has been much interest in the development of breast cancer prevention strategies. Pharmacologic approaches are the most developed at this time. The nonsteroidal selective estrogen receptor modulator (SERM) tamoxifen, a mainstay in the management of breast cancer, has also been tested as a chemopreventive agent. 
    • Screening strategies for breast cancer include the triad of breast self-examination (BSE), clinical breast examination by a health care professional, and screening mammography. Although widely touted as an important component of early detection, BSE is of uncertain value.
    • Increased understanding of growth pathways of breast cancer has led to the identification of crucial nonendocrine pathways that are potential targets for therapy. One such target is the HER-2 protein, a transmembrane protein that is overexpressed in about 20% of breast cancers, generally because of gene amplification. 

Breast Cancer

    • There has been much interest in the development of breast cancer prevention strategies. Pharmacologic approaches are the most developed at this time. The nonsteroidal selective estrogen receptor modulator (SERM) tamoxifen, a mainstay in the management of breast cancer, has also been tested as a chemopreventive agent. 
    • Screening strategies for breast cancer include the triad of breast self-examination (BSE), clinical breast examination by a health care professional, and screening mammography. Although widely touted as an important component of early detection, BSE is of uncertain value.
    • Increased understanding of growth pathways of breast cancer has led to the identification of crucial nonendocrine pathways that are potential targets for therapy. One such target is the HER-2 protein, a transmembrane protein that is overexpressed in about 20% of breast cancers, generally because of gene amplification. 

Breast Cancer

    • There has been much interest in the development of breast cancer prevention strategies. Pharmacologic approaches are the most developed at this time. The nonsteroidal selective estrogen receptor modulator (SERM) tamoxifen, a mainstay in the management of breast cancer, has also been tested as a chemopreventive agent. 
    • Screening strategies for breast cancer include the triad of breast self-examination (BSE), clinical breast examination by a health care professional, and screening mammography. Although widely touted as an important component of early detection, BSE is of uncertain value.
    • Increased understanding of growth pathways of breast cancer has led to the identification of crucial nonendocrine pathways that are potential targets for therapy. One such target is the HER-2 protein, a transmembrane protein that is overexpressed in about 20% of breast cancers, generally because of gene amplification. 

Portal Hypertension

    • Use of HVPG to accurately diagnose portal hypertension
    • Child-Pugh score and MELD score in risk stratification and decision-making
    • Fibroelastography, multidetecter row CT scan, and capsule endoscopy as emerging modalities in detection of varices.

Trauma to the Thoracic Aorta

    • BTAI is now the gold standard n treating patients with these problems
    • The grade of injury with these lesions has been defined and there is controversy on which lesion should be treated and how emergently
    • Recently in the US a device changed its IFU because of complications after TEVAR for BTAI. It was being used outside its IFU.
    • Recent advancement on sizing and device differences between BTAI and other pathologies treated with TEVAR

Initial Management of Life-Threatening Trauma

    • Initial volume resuscitation should commence with 1 L isotonic crystalloid solution followed by blood products at 1:1:1 ratio (1 unit packed red blood cells to 1 unit fresh frozen plasma to 1 unit platelets) if the patient is not responsive to the initial fluid bolus.
    • In patients with massive hemorrhage or evidence of fibrinolysis, tranexamic acid has demonstrated improved survival if administered within 3 hours of injury.
    • Use of resuscitative endovascular balloon occlusion of the aorta may be an important adjunct in the control of life-threatening abdominal or pelvic hemorrhage.
    • In cases of external hemorrhage of an extremity, a tourniquet should be used to control bleeding.

Pulmonary Function Testing

    • Spirometry has few absolute contraindications, although several conditions should merit caution and others may affect the quality of results. Pain, nausea, or other subjective discomforts, as well as altered mental status, will likely lead to poor results and therefore are relative contraindications.
    • The role of the carbon monoxide (CO) diffusing capacity (DLCO) test is to provide information on the transfer of gas from alveolar air to the bloodstream. DLCO reflects the overall efficiency of gas movement at each step from the mouth to the hemoglobin in the pulmonary capillary blood.
    • Certain substances and behavior should be avoided prior to testing as they can lead to either false positives or false negatives. Recent upper respiratory tract infection and cigarette smoking can elevate bronchial hyperresponsiveness. 
« Previous | Next »
Updates per yearSpecialty updatesNumber of sections